SCig: Subcutaneous Infusions for CVID/PIDD

In my personal journey managing Common Variable Immunodeficiency (CVID) with subcutaneous immunoglobulin (SCIG) infusions, I've learned that adapting the infusion technique can make a significant difference. I typically use a High-Flo 3-Leg Set for my treatments, which is designed with three infusion lines, also called needles, to deliver the medication. However, there have been occasions where one needle may have accidentally contacted a nerve, causing discomfort. This experience highlighted the critical importance of never reusing a needle once it has been withdrawn from the skin, to reduce the risk of infection and nerve injury. To manage such situations, I switched to running only two lines instead of three. Since the High-Flo 3-Leg Set’s needles are non-separable, using just two lines increased the overall infusion volume per line, which is manageable but requires careful monitoring. When adjusting the number of infusion sites like this, be sure to keep detailed logs, similar to my infusion logs that track dates, needle sizes such as 1.2 inch by 2.6 inch dimensions marked on alcohol prep pads, and any reactions. These logs help identify patterns and improve safety. Proper preparation is also essential—using alcohol prep pads thoroughly at the infusion sites before inserting needles helps reduce infection risk. Moreover, rotating infusion sites regularly can prevent tissue damage and discomfort. Overall, managing SCIG infusions for CVID or other Primary Immunodeficiency Diseases (PIDD) requires a personalized approach. Share your experiences within support forums or health communities tagged with #cvid, as peer advice can provide practical tips. Always consult with your healthcare provider when making any changes to your infusion routine to ensure treatments remain safe and effective. This proactive approach helped me maintain consistent and comfortable infusions, enhancing my treatment adherence and quality of life.